does insurance cover glp 1 drugs How many adults with private health could use GLP-1 Poll: 1 in 8 Adults
Description
LPL: lipoprotein lipase
Clinicians and patients need to always balance benefit and harm of treatments in light of their alternatives
Expansion is supported by improved healthcare access, growing pharmaceutical distribution networks, and increasing awareness of medical weight management
The rate at which GLP-1 use is growing means that this secondary effect could have a significant public health impact even without intentional use of GLP-1 for addiction treatment
Supply Challenges and Compounding Restrictions Shortages and Compounding: Despite growth, the market faces challenges from supply shortages of key drugs like Ozempic and Trulicity, leading to compounding restrictions due to safety concerns
Novo Nordisk's main competitor is Eli Lilly, which makes Zepbound and Mounjaro
